A detailed history of Embree Financial Group transactions in Johnson & Johnson stock. As of the latest transaction made, Embree Financial Group holds 20,483 shares of JNJ stock, worth $3.14 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
20,483
Previous 20,406 0.38%
Holding current value
$3.14 Million
Previous $2.98 Billion 11.3%
% of portfolio
0.59%
Previous 0.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$145.48 - $167.38 $11,201 - $12,888
77 Added 0.38%
20,483 $3.32 Billion
Q2 2024

Aug 01, 2024

SELL
$144.38 - $157.78 $19,058 - $20,826
-132 Reduced 0.64%
20,406 $2.98 Billion
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $122,779 - $128,727
-791 Reduced 3.71%
20,538 $3.25 Billion
Q4 2023

Apr 30, 2024

BUY
$145.6 - $158.88 $3.11 Million - $3.39 Million
21,329 New
21,329 $3.34 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Embree Financial Group Portfolio

Follow Embree Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Embree Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Embree Financial Group with notifications on news.